Abstract: The invention features a composition comprising a botanical rich alcoholic beverage that retains its sensory qualities and health benefits stably over time in storage. Health effects of the beverage protect the liver from the effects of alcohol induced oxidative stress. The beverage product remains stable under normal storage conditions for at least 6 months, e.g., in excess of 2 years. Dried herbs/plants/fruits have been historically consumed based on the belief and often supportive scientific evidence that such botanicals protect from injurious exposures and contribute generally to health maintenance. A composition of the invention features key phytonutrients such as epigallocatechin gallate (EGCG) in an alcoholic beverage stabilized to produce an alcoholic beverage that protects the liver against alcohol damage and presents with its unique taste and color.

Abstract: A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica juncea extract, Brassica oleracea italica extract, Brassica oleracea capitata extract, Brassica oleracea botrytis extract, and Brassica oleracea acephala extract. The composition further comprises one or more selected from the group consisting of: Curcuma longa extract, curcuminoids, tetrahydrocurcuminoids, metabolites of curcuminoids or tetrahydrocurcuminoids, and derivatives of curcuminoids or tetrahydrocurcuminoids. The composition further comprises one or more selected from the group consisting of: Camellia oleifera extract, Camellia sinensis extract, green tea extract and white tea extract; Wasabia japonica extract; Bacopa monnieri extract; Silybum marianum extract; and one or both of Piper nigrum extract or tetrahydropiperine.

Abstract: A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica juncea extract, Brassica oleracea italica extract, Brassica oleracea capitata extract, Brassica oleracea botrytis extract, and Brassica oleracea acephala extract. The composition further comprises one or more selected from the group consisting of: Curcuma longa extract, curcuminoids, tetrahydrocurcuminoids, metabolites of curcuminoids or tetrahydrocurcuminoids, and derivatives of curcuminoids or tetrahydrocurcuminoids. The composition further comprises one or more selected from the group consisting of: Camellia oleifera extract, Camellia sinensis extract, green tea extract and white tea extract; Wasabia japonica extract; Bacopa monnieri extract; Silybum marianum extract; and one or both of Piper nigrum extract or tetrahydropiperine.

Abstract: A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica juncea extract, Brassica oleracea italica extract, Brassica oleracea capitata extract, Brassica oleracea botrytis extract, and Brassica oleracea acephala extract. The composition further comprises one or more selected from the group consisting of: Curcuma longa extract, curcuminoids, tetrahydrocurcuminoids, metabolites of curcuminoids or tetrahydrocurcuminoids, and derivatives of curcuminoids or tetrahydrocurcuminoids. The composition further comprises one or more selected from the group consisting of: Camellia oleifera extract, Camellia sinensis extract, green tea extract and white tea extract; Wasabia japonica extract; Bacopa monnieri extract; Silybum marianum extract; and one or both of Piper nigrum extract or tetrahydropiperine.

Abstract: A composition for the topical application on a mammalian skin comprises one or more Brassica plant extracts selected from the group consisting of: Brassica juncea extract, Brassica oleracea italica extract, Brassica oleracea capitata extract, Brassica oleracea botrytis extract, and Brassica oleracea acephala extract. The composition further comprises one or more selected from the group consisting of: Curcuma longa extract, curcuminoids, tetrahydrocurcuminoids, metabolites of curcuminoids or tetrahydrocurcuminoids, and derivatives of curcuminoids or tetrahydrocurcuminoids. The composition further comprises one or more selected from the group consisting of: Camellia oleifera extract, Camellia sinensis extract, green tea extract and white tea extract; Wasabia japonica extract; Bacopa monnieri extract; Silybum marianum extract; and one or both of Piper nigrum extract or tetrahydropiperine.

Abstract: Methods and systems of establishing a program to maximize weight loss include determining an energy deficiency and an exercise regimen for a particular female individual based on an increased concentration or level of at least one ovarian hormone, such as an oestrogen or progesterone. The increased concentration of the at least one ovarian hormone may be determined by calculating a phase of a menstrual cycle of the female subject. The daily energy deficiency may be calculated and an exercise regimen determined based on the phase of the menstrual cycle. By decreasing the daily energy deficiency and increasing the exercise regimen while the concentration of at least one ovarian hormone is increased, weight loss (i.e., fat loss) may be maximized.

Abstract: Methods and systems of establishing a program to maximize weight loss include determining an energy deficiency and an exercise regimen for a particular female individual based on an increased concentration or level of at least one ovarian hormone, such as an oestrogen or progesterone. The increased concentration of the at least one ovarian hormone may be determined by calculating a phase of a menstrual cycle of the female subject. The daily energy deficiency may be calculated and an exercise regimen determined based on the phase of the menstrual cycle. By decreasing the daily energy deficiency and increasing the exercise regimen while the concentration of at least one ovarian hormone is increased, weight loss (i.e., fat loss) may be maximized.

Abstract: A topical composition for the protection of skin from damage caused by ultraviolet radiation. The composition includes a direct antioxidant and a phase 2 enzyme inducer (indirect antioxidant) in cosmetic and dermopharmaceutical compositions that protects and prevents skin damage and aging caused by UV radiation. In a particular embodiment, the composition includes a broccoli extract in combination with a composition including Hibiscus flower extract, Ferula Assa Foetida root extract, pear fruit extract, and green tea leaf extract, which exhibit a synergistic effect in protecting the skin from the adverse effects of ultraviolet radiation. In another embodiment, the composition further includes Vitamin C and Vitamin E. The antioxidant compositions can be incorporated into cosmetics, pharmaceutical compositions, sunscreen products, moisturizing lotions, skin toners, and other skin care products.

Abstract: A composition of matter includes an effective amount of strontium carbonate for affecting bone metabolism. The composition is substantially free of calcium to avoid absorption competition in the digestive tract. The composition is also preferably substantially free of chelating agents, phosphate, phytic acid, oxalates, insoluble fibers, and non-strontium divalent cations or other materials that compete with strontium ions for absorption in the human digestive tract. Other ingredients are optionally added to increase strontium absorption or for their independent positive effective on bone health, including for example vitamin D and vitamin K, quercetin dihydrate, and hesperidin. The composition is preferably administered as a chewable food by blending with a chewable food matrix to form a palatable food that is readily consumed.

Abstract: Compositions containing nicotine and/or nicotinic acetylcholine receptor agonists are provided for administration in therapeutically effective amounts to enhance muscle development in animals, the nicotine and/or nicotinic acetylcholine receptor agonists being particularly derived from natural sources that produce beneficially high amounts nicotine and/or nicotinic acetylcholine receptor agonists which is also well-tolerated and ingestible for the intended purpose.